Department of Emergency Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada
British Columbia Emergency Health Services, Vancouver, British Columbia, Canada.
BMJ Open Qual. 2021 Dec;10(4). doi: 10.1136/bmjoq-2021-001519.
Coronary artery disease is the second leading cause of death in Canada. Time to treatment in ST-elevation myocardial infarction (STEMI) is directly related to morbidity and mortality. Thrombolysis is the primary treatment for STEMI in many regions of Canada because of prolonged transport times to percutaneous coronary intervention-capable centres. To reduce time from first medical contact (FMC) to thrombolysis, some emergency medical services (EMS) systems have implemented prehospital thrombolysis (PHT). PHT is not a novel concept and has a strong evidence base showing reduced mortality.Here, we describe a quality improvement initiative to decrease time from FMC to thrombolysis using PHT and aim to describe our methods and challenges during implementation. We used a quality improvement framework to collaborate with hospitals, EMS, cardiology, emergency medicine and other stakeholders during implementation. We trained advanced care paramedics to administer thrombolysis in STEMI with remote cardiologist support and aimed to achieve a guideline-recommended median FMC to needle time of <30 min in 80% of patients.Overall, we reduced our median FMC to needle time by 70%. Our baseline patients undergoing in-hospital thrombolysis had a median time of 84 min (IQR 62-116 min), while patients after implementation of PHT had a median time of 25 min (IQR 23-39 min). Patients treated within the guideline-recommended time from FMC to needle of <30 min increased from 0% at baseline to 61% with PHT. Return on investment analysis showed $2.80 saved in acute care costs for every $1.00 spent on the intervention.While we did not achieve our goal of 80% compliance with FMC to needle time of <30 min, our results show that the intervention substantially reduced the FMC to needle time and overall cost. We plan to continue with ongoing implementation of PHT through expansion to other communities in our province.
冠心病是加拿大的第二大死因。ST 段抬高型心肌梗死(STEMI)的治疗时间与发病率和死亡率直接相关。由于向有经皮冠状动脉介入能力的中心转运时间延长,溶栓治疗是加拿大许多地区治疗 STEMI 的主要方法。为了缩短从首次医疗接触(FMC)到溶栓的时间,一些紧急医疗服务(EMS)系统已经实施了院前溶栓(PHT)。PHT 并不是一个新的概念,它有一个强有力的证据基础,表明可以降低死亡率。在这里,我们描述了一项质量改进计划,通过使用 PHT 来减少从 FMC 到溶栓的时间,并旨在描述实施过程中的方法和挑战。我们使用质量改进框架与医院、EMS、心脏病学、急诊医学和其他利益相关者合作。我们培训高级护理人员在远程心脏病专家的支持下对 STEMI 进行溶栓,并旨在使 80%的患者达到指南推荐的 FMC 至针时间中位数<30 分钟。总体而言,我们将 FMC 至针的中位数时间缩短了 70%。我们的基线患者在院内接受溶栓治疗的中位时间为 84 分钟(IQR 62-116 分钟),而在实施 PHT 后,患者的中位时间为 25 分钟(IQR 23-39 分钟)。在从 FMC 到针的指南推荐时间<30 分钟内接受治疗的患者从基线时的 0%增加到 PHT 时的 61%。投资回报分析显示,每花费 1 美元干预成本,可节省 2.80 美元急性护理费用。虽然我们没有达到 80%的患者符合 FMC 至针时间<30 分钟的目标,但我们的结果表明,该干预措施大大缩短了 FMC 至针的时间和总费用。我们计划继续通过向我省其他社区扩展来实施 PHT。